NCT03285633 Telephone-Based Mindfulness CBT for Patients in Community Settings With Advanced Cancer Status COMPLETED Phase NA
NCT03261011 Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03254173 Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia Status COMPLETED Phase PHASE2/PHASE3
NCT03252678 Efficacy of Self-education Program for Advanced Care Planning(RCT) Status COMPLETED Phase NA
NCT03243643 Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT03219775 Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT03203876 A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT03195699 Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers Status COMPLETED Phase PHASE1
NCT03192943 A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors Status COMPLETED Phase PHASE1
NCT03181854 Randomized Controlled Trial of Integrated Early Palliative Care Status COMPLETED Phase NA
NCT03177291 Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC Status COMPLETED Phase PHASE1
NCT03175224 APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors Status RECRUITING Phase PHASE2
NCT03168035 Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT03140137 Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases Status COMPLETED Phase N/A
NCT03137121 Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients Status COMPLETED Phase PHASE2/PHASE3
NCT03129139 A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1